期刊文献+

氟伐他汀对急性心肌梗死患者循环单核细胞基质金属蛋白酶9和组织因子表达的影响 被引量:2

Effect of Fluvastatin on Expression of Matrix Metalloproteinase-9,Tissue Factor from Circulating Monocytes in Patients with Acute Myocardial Infarction
下载PDF
导出
摘要 目的观察氟伐他汀对急性心肌梗死患者循环单核细胞基质金属蛋白酶9、组织因子表达的影响。方法分离30例急性心肌梗死患者和30例正常对照者循环血单核细胞,在体外无血清培养,设两孔,一孔直接培养,一孔加入氟伐他汀(360μg/L)干预48h,酶联免疫吸附法测定上清液中基质金属蛋白酶9、组织因子的含量。结果急性心肌梗死非干预组基质金属蛋白酶9、组织因子均高于正常对照非干预组(351±141μg/L比121±10μg/L,P<0.01;41.4±13.6ng/L比25.5±5.4ng/L,P<0.01)。急性心肌梗死氟伐他汀组较非干预组基质金属蛋白酶9和组织因子表达明显下降(226±89μg/L比351±141μg/L,P<0.01;31.4±11.2ng/L比41.4±13.6ng/L,P<0.05)。结论急性心肌梗死患者循环血单核细胞产生基质金属蛋白酶9、组织因子增加,氟伐他汀能抑制单核细胞表达基质金属蛋白酶9、组织因子。 Aim To investigate the effect of fluvastatin on expression of matrix metalloproteinase-9 (MMP-9), tissue factor (TF) from the peripheral blood monocytes in patients with acute myocardial infarction (AMI). Methods Monocytes from 30 AMI patients and 30 control subjects were separated and added into two bores, one cultivated directly, one cultivated with fluvastatin (360 μg/L). The contents of MMP-9, TF were assayed by enzyme linked immunosorbent assay (ELISA). Results Compared with control noninterfering group, the productions of MMP-9, TF in AMI noninterfering group were increased significantly (351±141μg/Lvs121±10μg/L, P〈0.01;41.4±13.6ng/Lvs25.5±5.4ng/L, P〈0.01). In AMI group, compared with the noninterfering group, the productions of MMP-9, TF in fluvastatin group have been decreased significantly (226±89μg/Lvs351±141 μg/L, P〈0.01; 31.4±11.2ng/L vs 41.4±13.6ng/L, P〈0.05). Conclusion The productions of MMP-9, TF in monocytes from patients with AMI were increased. Fluvastatin inhibited the expression of MMP-9 and TF.
出处 《中国动脉硬化杂志》 CAS CSCD 2006年第3期237-239,共3页 Chinese Journal of Arteriosclerosis
基金 江苏省社会发展基金资助项目(BS2002009)
关键词 内科学 氟伐他汀 急性心肌梗死 基质金属蛋白酶9 组织因子 单核细胞 Fluvastatin Acute Myocardial Infarction Matrix Metalloproteinase-9 Tissue Factor Monocytes
  • 相关文献

参考文献9

  • 1Plutzky J. Atherosclerotic plaque rupture: emerging insights and opportunities [J]. Am J Cardiol, 1999, 84(1):15-20
  • 2Rabbani R, Topol EJ. Strategies to achieve coronary arterial phaque stabilization [J]. Cardiovasc Res, 1999, 41(2):402-407
  • 3Ritchie ME. Nuclear factor-kappaB is selectively and markedly activated in humans with ustable angina pectoris[J]. Circulation, 1998, 98(17):1707-713
  • 4Feldman LJ, Mazighi M, Scheuble A, Deux JF, De Benedetti E, Badier-Commander C, et al. Differential expression of matrix metalloproteinases after stent implantation and balloon angioplasty in the hypercholesterolemic rabbit[J]. Circlation, 2001, 103(25):3117-122
  • 5Cho A, Reidy MA. Matrix metalloproteinase-9 is necessary for the regulation of smooth muscle cell replication and migration after arterial injury[J]. Circ Res, 2002, 91(9):845-851
  • 6Aikawan M, Rabkin E, Sugiyamas S, Voglic SJ, Fukumoto Y, Furaukawa Y, et al. An HMG- CoA reductase inhibitor, cerivastatin, suppresses growth of macrophages expressing matrix metalloproteinases and tissue factor in vivo and in vitro [J]. Circulation, 2001, 103(2):276-284
  • 7Dollery CM, McEwan JR, Henney AM. Matrix metalloproteinase and cardio vascular disease[J]. Circ Res, 1995, 77(5):863-868
  • 8Sambola A, Osende J, Hathcock J, Degen M, Nemerson Y, Fuster V, et al. Role of risk factors in the modulation of tissue factor activity and blood thrombogenicity[J]. Circulation, 2003, 107(7):973-977
  • 9Marx N, Mackman N, Schonbeck U, Yilmaz , Hombach V, Libby P, et al. PPARalpha activators inhibit tissue factor expression and activity in human monocytes[J]. Circulation, 2001,103(2):213-219

同被引文献28

  • 1殷忠,李兰荪,张荣庆,刘安恒,栾荣华,王海昌.冠心病患者外周血MMP-9、CRP的变化及其临床意义[J].中国康复医学杂志,2006,21(4):318-321. 被引量:7
  • 2LIBBY P. Molecular basis of the acute coronary syndrome [ J 1. Circulation, 1995,91:2841 - 2845.
  • 3DOLHY GM, MCEWAN JR, HENNEY AM. Matrix metanoprotesse and cardiovascular disease[ J ]. Cite Res, 1995,77:863 - 868.
  • 4HERMAN MP,SUKIIOVA GK, LIBBY P. Expression of neutrophil collagenase( matrix metalloprotease - 8 ) in human atheroma : a novel collagenic pathway suggested by transcriptional profiling[ J ]. Circulation ,2001,104( 16 ) : 1899 - 1904.
  • 5FELDMAN LJ, MAZIGHI M, SCHEUBLE A, et al. Diferential expression of matrix metalloproteinases after stent implantation aml balloon angioplasty in the hypercholesterolemic rabbit [ J ]. Circulaaon,2001,103 (25) : 117 - 122.
  • 6Steffel J,Lüscher TF,Tanner FC.Tissue factor in cardio-vascular diseases:molecular mechanisms and clinical im-plications[J].Circulation,2006,113(5):722-731.
  • 7Wolfovitz F.The pleiotropic effects of statins[J].Hare-fuah,2005,144(8):577-582.
  • 8Zawadzki C,Silsen S,Richard F,et a1.Dyslipidemiashifts the tissue factor/tissue factor pathway inhibitor bal-ance toward increased thrombogenicity in atheroscleroticplaques:evidence for a corrective effect of statins[J].Ath-erosclerosis,2007,195:117-125.
  • 9Nagata K,Ishibashi T,Sakamoto T,et al.Rho/Rho-kinaseis involved in the synthesis of tissue factor in human mono-cytes[J].Atherosclerosis,2002,163(1):39-47.
  • 10Hiroki J,Shimokawa H,Higashi M,et a1.Inflammatorystimuli upregulate Rho-kinase in human coronary vascularsmooth muscle cells[J].Mol Cell Cardiol,2004,37:537-546.

引证文献2

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部